Literature DB >> 19470441

Rapid resolution of GVHD after orthotopic liver transplantation in a patient treated with alefacept.

Christy J Stotler, Bijan Eghtesad, Eric Hsi, Bernard Silver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19470441     DOI： 10.1182/blood-2009-02-207431

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Advances in immunosuppression for renal transplantation.

Authors:  Antoine Durrbach; Helene Francois; Severine Beaudreuil; Antoine Jacquet; Bernard Charpentier
Journal:  Nat Rev Nephrol       Date:  2010-02-02       Impact factor: 28.314

Review 2.  Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.

Authors:  Arvind R Murali; Subhash Chandra; Zoe Stewart; Bruce R Blazar; Umar Farooq; M Nedim Ince; Jeffrey Dunkelberg
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

Review 3.  Graft-Versus-Host Disease After Liver Transplantation.

Authors:  Ashley Wood; Bijan Eghtesad; Christina C Lindenmeyer
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-26

4.  Dermatologic manifestations of solid organ transplantation-associated graft-versus-host disease: A systematic review.

Authors:  Grace Y Kim; Leah A Schmelkin; Mark D P Davis; Rokea A El-Azhary; Ann M Farrell; Alexander Meves; Julia S Lehman
Journal:  J Am Acad Dermatol       Date:  2017-12-27       Impact factor: 11.527

5.  Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation.

Authors:  Xiao-Bo Chen; Jie Yang; Ming-Qing Xu; Tian-Fu Wen; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

Review 6.  Acute graft versus host disease after orthotopic liver transplantation.

Authors:  Inga Mandac Rogulj; Joachim Deeg; Stephanie J Lee
Journal:  J Hematol Oncol       Date:  2012-08-13       Impact factor: 17.388

7.  Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?

Authors:  Asifa Zaidi; Qinglai Meng; Daniel Popkin
Journal:  Immunotherapy (Los Angel)       Date:  2015-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.